Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Cell Line - Dogs

Terms

50Cell Line
41Dogs
31Antiviral Agents (pharmacology)
31Influenza A virus (drug effects)
11Antiviral Agents (chemistry)
19Virus Replication (drug effects)

Associations

Freq.WeightAssociation
300.663Cell Line - Dogs
190.613Antiviral Agents (pharmacology) - Influenza A virus (drug effects)
110.596Antiviral Agents (chemistry) - Antiviral Agents (pharmacology)
100.412Influenza A virus (drug effects) - Virus Replication (drug effects)
130.365Antiviral Agents (pharmacology) - Dogs
120.337Dogs - Influenza A virus (drug effects)
90.322Dogs - Virus Replication (drug effects)
110.279Antiviral Agents (pharmacology) - Cell Line
100.254Cell Line - Influenza A virus (drug effects)

Documents par ordre de pertinence
001A44 (1998) Daisei Miyamoto [Japon] ; Yuki Kusagaya [Japon] ; Naoko Endo [Japon] ; Ayako Sometani [Japon] ; Seiji Takeo [Japon] ; Takashi Suzuki [Japon] ; Yaeno Arima [Japon] ; Katsuyuki Nakajima [États-Unis] ; Yasuo Suzuki [Japon]Thujaplicin–copper chelates inhibit replication of human influenza viruses
000915 (2013) Takayuki Komatsu [Japon] ; Nobuo Kido ; Tsuyoshi Sugiyama ; Takashi YokochiAntiviral activity of acidic polysaccharides from Coccomyxa gloeobotrydiformi, a green alga, against an in vitro human influenza A virus infection.
000E68 (2010) Katrina Sleeman [États-Unis] ; Vasiliy P. Mishin ; Varough M. Deyde ; Yousuke Furuta ; Alexander I. Klimov ; Larisa V. GubarevaIn vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.
001984 (1999) Antonios Kolocouris [Grèce] ; Dimitrios Tataridis [Grèce] ; George Fytas [Grèce] ; Thomas Mavromoustakos [Grèce] ; George B. Foscolos [Grèce] ; Nicolas Kolocouris [Grèce] ; Erik De Clercq [Belgique]Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus a activity relationship study using a combination of NMR spectroscopy and molecular modeling
000C41 (2011) Huaxing Wu [République populaire de Chine] ; Beili Li [République populaire de Chine] ; Xue Wang [République populaire de Chine] ; Mingyuan Jin [République populaire de Chine] ; Guonian Wang [République populaire de Chine]Inhibitory Effect and Possible Mechanism of Action of Patchouli Alcohol against Influenza A (H2N2) Virus
001574 (2005) I A Leneva ; I T Fediakina ; T A Gus'Kova ; R G Glushkov[Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A].
001646 (2005) Takashi Suzuki [Japon] ; Tadanobu Takahashi [Japon] ; Chao-Tan Guo [Japon, République populaire de Chine] ; Kazuya I.-P. Jwa Hidari [Japon] ; Daisei Miyamoto [Japon] ; Hideo Goto [Japon] ; Yoshihiro Kawaoka [Japon, États-Unis] ; Yasuo Suzuki [Japon]Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication
001751 (2002) Christoph Scholtissek ; Jürgen Stech ; Scott Krauss ; Robert G. WebsterCooperation between the Hemagglutinin of Avian Viruses and the Matrix Protein of Human Influenza A Viruses
001B04 (1998) C. Scholtissek [États-Unis] ; G. Quack [Allemagne] ; H. D Klenk [Allemagne] ; R. G Webster [États-Unis]How to overcome resistance of influenza A viruses against adamantane derivatives
001B20 (1998) S. Bantia [États-Unis] ; A. A. Ghate [États-Unis] ; S. L. Ananth [États-Unis] ; Y. Sudhakar Babu [États-Unis] ; G. M. Air [États-Unis] ; G. M. Walsh [États-Unis]Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140
001B24 (1997) O. Andersen [Danemark] ; K. Vilsgaard Ravn ; I. Juul S Rensen ; G. Jonson ; E. Holm Nielsen ; S E SvehagSerum amyloid P component binds to influenza A virus haemagglutinin and inhibits the virus infection in vitro.
001C03 (1996) E H Nasser [États-Unis] ; A K Judd ; A. Sanchez ; D. Anastasiou ; D J BucherAntiviral activity of influenza virus M1 zinc finger peptides.
001C09 (1996) Nicolas Kolocouris [Belgique] ; Antonios Kolocouris [Belgique] ; George B. Foscolos [Belgique] ; George Fytas [Belgique] ; Johan Neyts [Belgique] ; Elisabeth Padalko [Belgique] ; Jan Balzarini [Belgique] ; Robert Snoeck [Belgique] ; Graciela Andrei [Belgique] ; Erik De Clercq [Belgique]Synthesis and Antiviral Activity Evaluation of Some New Aminoadamantane Derivatives. 2
002633 (1982) L M Garmashova ; G F Leontieva ; Dubrovina TYa ; G I AleksandrovaPartial change of the ts-phenotype of cold-adapted influenza virus strain grown in canine kidney cells in the presence of trypsin.
000196 (2018) Irina V. Ilyina [Russie] ; Vladimir V. Zarubaev [Russie] ; Irina N. Lavrentieva [Russie] ; Anna A. Shtro [Russie] ; Iana L. Esaulkova [Russie] ; Dina V. Korchagina [Russie] ; Sophia S. Borisevich [Russie] ; Konstantin P. Volcho [Russie] ; Nariman F. Salakhutdinov [Russie]Highly potent activity of isopulegol-derived substituted octahydro-2H-chromen-4-ols against influenza A and B viruses.
000743 (2014) Wael M. Abdel-Mageed [Égypte] ; Soad A H. Bayoumi [Égypte] ; Caixia Chen [République populaire de Chine] ; Christopher J. Vavricka [République populaire de Chine] ; Li Li [République populaire de Chine] ; Ajamaluddin Malik [Arabie saoudite] ; Huanqin Dai [République populaire de Chine] ; Fuhang Song [République populaire de Chine] ; Luoqiang Wang [République populaire de Chine] ; Jingyu Zhang [République populaire de Chine] ; George F. Gao [République populaire de Chine] ; Yali Lv [République populaire de Chine] ; Lihong Liu [République populaire de Chine] ; Xueting Liu [République populaire de Chine] ; Hanaa M. Sayed [Égypte] ; Lixin Zhang [République populaire de Chine]Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum anti-viral activity.
000C33 (2011) Peter G. Mohr [Australie] ; Henriette Geyer ; Jennifer L. Mckimm-BreschkinMixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors.
001125 (2009) Irina A. Leneva [Royaume-Uni] ; Rupert J. Russell ; Yury S. Boriskin ; Alan J. HayCharacteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol.
001270 (2008) Antonios Kolocouris [Grèce] ; Philip Spearpoint ; Stephen R. Martin ; Alan J. Hay ; Marta L Pez-Querol ; Francesc X. Sureda ; Elizaveta Padalko ; Johan Neyts ; Erik De ClercqComparisons of the influenza virus A M2 channel binding affinities, anti-influenza virus potencies and NMDA antagonistic activities of 2-alkyl-2-aminoadamantanes and analogues.
001391 (2007) Jae Min Song [Corée du Sud] ; Ki Duk Park ; Kwang Hee Lee ; Young Ho Byun ; Ju Hee Park ; Sung Han Kim ; Jae Hong Kim ; Baik Lin SeongBiological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.
001978 (1999) F. Li [République populaire de Chine] ; Q J Wang ; B L Zhu ; M. WangAntiviral effects of rhIFN-alpha 1 against seven influenza viruses.
002D77 (????) S G Markushin ; B V Sinitsyn ; V P Ginzburg ; A M Kha Der ; A I Klimov[The mechanisms of the antiviral action of the bora-adamantane derivative preparation BG-12].
000164 (2018) Paul Santner [Danemark] ; João Miguel Da Silva Martins [Danemark] ; Caroline Kampmeyer [Danemark] ; Rasmus Hartmann-Petersen [Danemark] ; Jonas S. Laursen [Danemark] ; Amelie Stein [Danemark] ; Christian A. Olsen [Danemark] ; Isaiah T. Arkin [Israël] ; Jakob R. Winther [Danemark] ; Martin Willemoës [Danemark] ; Kresten Lindorff-Larsen [Danemark]Random Mutagenesis Analysis of the Influenza A M2 Proton Channel Reveals Novel Resistance Mutants.
000342 (2017) S. Kannan [Inde] ; P. Kolandaivel [Inde]Antiviral potential of natural compounds against influenza virus hemagglutinin.
000C10 (2011) Christopher J. Vavricka [République populaire de Chine] ; Qing Li [République populaire de Chine] ; Yan Wu [République populaire de Chine] ; Jianxun Qi [République populaire de Chine] ; Mingyang Wang [République populaire de Chine] ; Yue Liu [République populaire de Chine] ; Feng Gao [République populaire de Chine] ; Jun Liu [République populaire de Chine] ; Enguang Feng [République populaire de Chine] ; Jianhua He [République populaire de Chine] ; Jinfang Wang [République populaire de Chine] ; Hong Liu [République populaire de Chine] ; Hualiang Jiang [République populaire de Chine] ; George F. Gao [République populaire de Chine]Structural and Functional Analysis of Laninamivir and its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA Inhibition
000C94 (2011) Nicola Clementi [Italie] ; Donata De Marco ; Nicasio Mancini ; Laura Solforosi ; Guisella J. Moreno ; Larisa V. Gubareva ; Vasiliy Mishin ; Andrea Di Pietro ; Elisa Vicenzi ; Antonio G. Siccardi ; Massimo Clementi ; Roberto BurioniA human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes.
000E65 (2010) Rei-Lin Kuo ; Chen Zhao ; Meghana Malur ; Robert M. KrugInfluenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-β transcription
000E81 (2010) Zhongying Chen [États-Unis] ; Weijia Wang ; Helen Zhou ; Amorsolo L. Suguitan ; Cindy Shambaugh ; Lomi Kim ; Jackie Zhao ; George Kemble ; Hong JinGeneration of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs.
000F44 (2010) J. Theo M. Voeten [Pays-Bas] ; Irina V. Kiseleva [Pays-Bas, Russie] ; Harrie L. Glansbeek [Pays-Bas] ; Stephanie M. C. Basten [Pays-Bas] ; Sandra K. M. Drieszen-Van Der Cruijsen [Pays-Bas] ; Larisa G. Rudenko [Russie] ; Han Van Den Bosch [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas]Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model
001086 (2009) Martin Michaelis [Allemagne] ; Janina Geiler ; Denise Klassert ; Hans Wilhelm Doerr ; Jindrich CinatlInfection of human retinal pigment epithelial cells with influenza A viruses.
001100 (2009) Olive T. W. Li [République populaire de Chine] ; Michael C. W. Chan [République populaire de Chine] ; Cynthia S. W. Leung [République populaire de Chine] ; Renee W. Y. Chan [République populaire de Chine] ; Yi Guan [République populaire de Chine] ; John M. Nicholls [République populaire de Chine] ; Leo L. M. Poon [République populaire de Chine]Full Factorial Analysis of Mammalian and Avian Influenza Polymerase Subunits Suggests a Role of an Efficient Polymerase for Virus Adaptation
001179 (2009) Jennifer Uhlendorff [Allemagne] ; Tatyana Matrosovich [Allemagne] ; Hans-Dieter Klenk [Allemagne] ; Mikhail Matrosovich [Allemagne]Functional significance of the hemadsorption activity of influenza virus neuraminidase and its alteration in pandemic viruses
001373 (2007) Fred Y. Aoki [Canada] ; Guy Boivin ; Noel RobertsInfluenza virus susceptibility and resistance to oseltamivir.
001428 (2007) E. N. Prokudina [Russie] ; N. P. Semenova [Russie] ; V. M. Chumakov [Russie] ; T. A. Grigorieva [Russie]Non-compact nucleocapsid protein multimers in influenza-virus-infected cells
001496 (2006) Kwang-Hee Lee [Corée du Sud] ; Sang-Uk Seo ; Jae-Min Song ; Chung-Min Lee ; Hyun-Ah Kim ; Baik L. SeongCharacterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
001566 (2006) Grigoris Zoidis [Grèce] ; Christos Fytas [Grèce] ; Loannis Papanastasiou [Grèce] ; George B. Foscolos [Grèce] ; George Fytas [Grèce] ; Elizaveta Padalko [Belgique] ; Erik De Clercq [Belgique] ; Lieve Naesens [Belgique] ; Johan Neyts [Belgique] ; Nicolas Kolocouris [Grèce]Heterocyclic rimantadine analogues with antiviral activity
001648 (2005) S. Al Faress [France] ; G. Cartet [France] ; O. Ferraris [France] ; H. Norder [France] ; M. Valette [France] ; B. Lina [France]Divergent genetic evolution of hemagglutinin in influenza A H1N1 and A H1N2 subtypes isolated in the south-France since the winter of 2001-2002.
001653 (2004) Thomas Palker [États-Unis] ; Irina Kiseleva ; Kimberly Johnston ; Qin Su ; Timothy Toner ; Christopher Szymkowiak ; Wan-Sang Kwan ; Boris Rubin ; Luba Petrukhin ; Joan Wlochowski ; Juanita Monteiro ; Nikolai Kraiouchkine ; Daniel Distefano ; Larisa Rudenko ; Alan Shaw ; Rima YouilProtective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
001699 (2004) I. Kiseleva [États-Unis, Russie] ; Q. Su [États-Unis] ; T. J. Toner [États-Unis] ; C. Szymkowiak [États-Unis] ; W.-S. Kwan [États-Unis] ; L. Rudenko [Russie] ; A. R. Shaw [États-Unis] ; R. Youil [États-Unis]Cell-based assay for the determination of temperature sensitive and cold adapted phenotypes of influenza viruses
001738 (2003) Grigoris Zoidis [Grèce] ; Nicolas Kolocouris [Grèce] ; George B. Foscolos [Grèce] ; Antonios Kolocouris [Grèce] ; George Fytas [Grèce] ; P. Karayannis [Grèce] ; Elizaveta Padalko [Belgique] ; Johan Neyts [Belgique] ; Erik De Clercq [Belgique]Are the 2-isomers of the drug rimantadine active anti-influenza A agents?
001962 (2000) Susan Duhaut [Royaume-Uni] ; Nigel J. Dimmock [Royaume-Uni]Approximately 150 Nucleotides from the 5′ End of an Influenza A Segment 1 Defective Virion RNA Are Needed for Genome Stability during Passage of Defective Virus in Infected Cells
001A38 (1999) M. Kobayashi [États-Unis] ; S. M. Davis [États-Unis] ; T. Utsunomiya [États-Unis] ; R. B. Pollard [États-Unis] ; F. Suzuki [États-Unis]Antiviral effect of gingyo-san, a traditional chinese herbal medicine, on influenza A2 virus infection in mice
002393 (1986) P. H. Russell [Royaume-Uni]Newcastle disease virus and two influenza viruses: Differing effects of acid and temperature on the uptake of infectious virus into bovine and canine kidney cell lines
002561 (1983) R. Mentel ; B. Helbig ; R. Klöcking ; L. Döhner ; M. Sprössig[Effectiveness of phenol body polymers against influenza virus A/Krasnodar/101/59/H2N2].
002A85 (1977) Margaret Tisdale [Royaume-Uni] ; D. J. Bauer [Royaume-Uni]THE RELATIVE POTENCIES OF ANTI‐INFLUENZA COMPOUNDS
002D98 (????) G M Vode Ko ; L A Zazimko ; V R Farashian ; V M Zhdanov[Parent and recombinant influenza virus A strains differing in the degree of remantadine sensitivity].
002E00 (????) Iu Z. Gendon ; S G Markushin ; T M Tsfasman ; I I Akopova ; N K Akhmatova ; I B Koptiaeva[New cold-adapted donor strains for live influenza vaccine].
002E06 (????) I V Kiseleva ; N V Larionova ; J T M. Voeten ; L C P. Teley ; S K M. Drieszen-Van Der Cruijsen ; J G M. Heldens ; J F Van Den Bosch ; L G Rudenko[Leading role of genes coding polymerase complex in attenuation of domestic donor viruses for A and B live influenza vaccine].
000042 (2019) M. Linster [Pays-Bas, Singapour] ; E. J. A. Schrauwen [Pays-Bas] ; S. Van Der Vliet [Pays-Bas] ; D. F. Burke [Royaume-Uni] ; P. Lexmond [Pays-Bas] ; T. M. Bestebroer [Pays-Bas] ; D. J. Smith [Royaume-Uni] ; S. Herfst [Pays-Bas] ; B. F. Koel [Pays-Bas] ; R. A. M. Fouchier [Pays-Bas]The Molecular Basis for Antigenic Drift of Human A/H2N2 Influenza Viruses
000044 (2019) Wenjuan Du [Pays-Bas] ; Hongbo Guo [Pays-Bas] ; Vera S. Nijman [Pays-Bas] ; Jennifer Doedt [Allemagne] ; Erhard Van Der Vries [Pays-Bas] ; Joline Van Der Lee [Pays-Bas] ; Zeshi Li [Pays-Bas] ; Geert-Jan Boons [Pays-Bas] ; Frank J. M. Van Kuppeveld [Pays-Bas] ; Erik De Vries [Pays-Bas] ; Mikhail Matrosovich [Allemagne] ; Cornelis A. M. De Haan [Pays-Bas]The 2nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin-neuraminidase-receptor balance
000176 (2018) Svetlana Shcherbik [États-Unis] ; Paul Carney [États-Unis] ; Nicholas Pearce [États-Unis] ; James Stevens [États-Unis] ; Vivien G. Dugan [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis]Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines
000385 (2016) Olivier Terrier [France] ; Coralie Carron [France] ; Beno De Chassey [France] ; Julia Dubois [France] ; Aurélien Traversier [France] ; Thomas Julien [France] ; Gaëlle Cartet [France] ; Anaïs Proust [France] ; Sabine Hacot [France] ; Denis Ressnikoff [France] ; Vincent Lotteau [France] ; Bruno Lina [France] ; Jean-Jacques Diaz [France] ; Vincent Moules [France] ; Manuel Rosa-Calatrava [France]Nucleolin interacts with influenza A nucleoprotein and contributes to viral ribonucleoprotein complexes nuclear trafficking and efficient influenza viral replication
000449 (2016) J Rgen De Jonge [Pays-Bas] ; Irina Isakova-Sivak [Russie] ; Harry Van Dijken [Pays-Bas] ; Sanne Spijkers [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Rineke De Jong [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Paul Roholl [Pays-Bas] ; Larisa Rudenko [Russie]H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets.
000509 (2015) Isabel Wendel [Allemagne] ; Dennis Rubbenstroth [Allemagne] ; Jennifer Doedt [Allemagne] ; Georg Kochs [Allemagne] ; Jochen Wilhelm [Allemagne] ; Peter Staeheli [Allemagne] ; Hans-Dieter Klenk [Allemagne] ; Mikhail Matrosovich [Allemagne]The Avian-Origin PB1 Gene Segment Facilitated Replication and Transmissibility of the H3N2/1968 Pandemic Influenza Virus
000513 (2015) Daniel Dlugolenski [États-Unis] ; Les Jones [États-Unis] ; Elizabeth Howerth [États-Unis] ; David Wentworth [États-Unis] ; S. Mark Tompkins [États-Unis] ; Ralph A. Tripp [États-Unis]Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression
000520 (2015) Petr Chlanda [Allemagne] ; Oliver Schraidt [Allemagne] ; Susann Kummer [Allemagne] ; James Riches [Allemagne] ; Heike Oberwinkler [Allemagne] ; Simone Prinz [Allemagne] ; Hans-Georg Kr Usslich [Allemagne] ; John A G. Briggs [Allemagne]Structural Analysis of the Roles of Influenza A Virus Membrane-Associated Proteins in Assembly and Morphology.
000602 (2015) Mariana Baz [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; James R. Zengel [États-Unis] ; Xing Cheng [États-Unis] ; John J. Treanor [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie]A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.
000652 (2014) Christopher D. O'Donnell [États-Unis] ; Leatrice Vogel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie]The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines.
000670 (2014) Jeremy C. Jones ; Tatiana Baranovich ; Bindumadhav M. Marathe ; Angela F. Danner ; Jon P. Seiler ; John Franks ; Elena A. Govorkova ; Scott Krauss ; Robert G. WebsterRisk Assessment of H2N2 Influenza Viruses from the Avian Reservoir
000805 (2013) Ai-Jun Chen [République populaire de Chine] ; Jian-Qiang Guo ; Li-Hong Yao ; Ji-Yong Yin ; Zhi-Qing Zhang[Establishment of mammalian cell lines for constitutive expression of influenza virus matrix protein 2].
000864 (2013) Wen He [République populaire de Chine] ; Wei Wang ; Huamin Han ; Lei Wang ; Ge Zhang ; Bin GaoMolecular basis of live-attenuated influenza virus.
000B47 (2012) Ashok K. Chockalingam [États-Unis] ; Danielle Hickman [États-Unis] ; Lindomar Pena [États-Unis] ; JIANQIANG YE [États-Unis] ; Andrea Ferrero [États-Unis] ; Jose R. Echenique [Argentine] ; HONGJUN CHEN [États-Unis] ; Troy Sutton [États-Unis] ; Daniel R. Perez [États-Unis]Deletions in the Neuraminidase Stalk Region of H2N2 and H9N2 Avian Influenza Virus Subtypes Do Not Affect Postinfluenza Secondary Bacterial Pneumonia
000F94 (2010) Erin M. Sorrell [États-Unis] ; HAICHEN SONG [États-Unis] ; Lindomar Pena [États-Unis] ; Daniel R. Perez [États-Unis]A 27-Amino-Acid Deletion in the Neuraminidase Stalk Supports Replication of an Avian H2N2 Influenza A Virus in the Respiratory Tract of Chickens
001345 (2008) Nigel J. Dimmock [Royaume-Uni] ; Edward W. Rainsford [Royaume-Uni] ; Paul D. Scott [Royaume-Uni] ; Anthony C. Marriott [Royaume-Uni]Influenza Virus Protecting RNA : an Effective Prophylactic and Therapeutic Antiviral
001347 (2008) David S. FedsonConfronting an influenza pandemic with inexpensive generic agents : can it be done?
001565 (2006) Nigel J. Dimmock [Royaume-Uni] ; Anthony C. Marriott [Royaume-Uni]In vivo antiviral activity : defective interfering virus protects better against virulent Influenza A virus than avirulent virus
001645 (2005) Colin R. Parrish [États-Unis] ; Yoshihiro Kawaoka [États-Unis, Japon]The origins of new pandemic viruses: The acquisition of new host ranges by canine parvovirus and influenza A viruses
001655 (2004) R. Youil [États-Unis] ; I. Kiseleva ; W-S Kwan ; C. Szymkowiak ; T J Toner ; Q. Su ; A. Klimov ; L. Rudenko ; A R ShawPhenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2).
001708 (2003) Tadanobu Takahashi [Japon] ; Takashi Suzuki ; Kazuya I-P Jwa Hidari ; Daisei Miyamoto ; Yasuo SuzukiA molecular mechanism for the low-pH stability of sialidase activity of influenza A virus N2 neuraminidases.
001747 (2002) Masato Hatta [États-Unis] ; Peter Halfmann ; Krisna Wells ; Yoshihiro Kawaoka [États-Unis]Human influenza a viral genes responsible for the restriction of its replication in duck intestine.
001972 (1999) D E Byers [États-Unis] ; K F LindahlPeptide affinity and concentration affect the sensitivity of M3-restricted CTLs induced in vitro.
001975 (1999) J. Stech ; X. Xiong ; C. Scholtissek ; R. G. WebsterIndependence of Evolutionary and Mutational Rates after Transmission of Avian Influenza Viruses to Swine
001994 (1999) Jon D. Reuter [États-Unis] ; Andrzej Myc [États-Unis] ; Michael M. Hayes [États-Unis] ; Zhonghong Gan [États-Unis] ; Rene Roy [États-Unis] ; Dujie Qin [États-Unis] ; Rui Yin [États-Unis] ; Lars T. Piehler [États-Unis] ; Roseita Esfand [États-Unis] ; Donald A. Tomalia [États-Unis] ; James R. Baker [États-Unis]Inhibition of Viral Adhesion and Infection by Sialic-Acid-Conjugated Dendritic Polymers
001997 (1999) Venkatram R. Atigadda [États-Unis] ; Wayne J. Brouillette [États-Unis] ; Franco Duarte [États-Unis] ; Yarlagadda S. Babu [États-Unis] ; Shanta Bantia [États-Unis] ; Pooran Chand [États-Unis] ; Naiming Chu [États-Unis] ; John A. Montgomery [États-Unis] ; David A. Walsh [États-Unis] ; Elise Sudbeck [États-Unis] ; James Finley [États-Unis] ; Gillian M. Air [États-Unis] ; Ming Luo [États-Unis] ; Graeme W. Laver [Australie]Hydrophobic benzoic acids as inhibitors of influenza neuraminidase
001A43 (1998) J. Jameson [États-Unis] ; J. Cruz ; F A EnnisHuman cytotoxic T-lymphocyte repertoire to influenza A viruses.
001B19 (1998) K. Sato [Japon] ; M. Suga [Japon] ; T. Akaike [Japon] ; S. Fujii [Japon] ; H. Muranaka [Japon] ; T. Doi [Japon] ; H. Maeda [Japon] ; M. Ando [Japon]Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice
001B98 (1997) T. Utsunomiya [États-Unis] ; M. Kobayashi [États-Unis] ; R. B. Pollard [États-Unis] ; F. Suzuki [États-Unis]Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus
001C00 (1996) H. Sagawa [Japon] ; A. Ohshima ; I. Kato ; Y. Okuno ; Y. IsegawaThe immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region.
001C90 (1996) K. G. Nicholson [Royaume-Uni]Use of antivirals in influenza in the elderly : Prophylaxis and therapy
001E47 (1994) M. Tamura [États-Unis] ; R. G. Webster ; F. A. Ennis [États-Unis]Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses
001F19 (1993) M. L. Herlocher [États-Unis] ; H. F. Maassab ; R. G. Webster [États-Unis]Molecular and biological changes in the cold-adapted "master strain" A/AA/6/60 (H2N2) influenza virus
001F27 (1992) S Q Li [États-Unis] ; J L Schulman ; T. Moran ; C. Bona ; P. PaleseInfluenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes.
002139 (1989) H. Aso [Japon] ; F. Suzuki ; T. Ebina ; N. IshidaAntiviral activity of carboxyethylgermanium sesquioxide (Ge-132) in mice infected with influenza virus.
002270 (1988) R. B. Belshe ; M. Hall Smith ; C. B. Hall ; R. Betts ; A. J. HayGenetic basis of resistance to rimantadine emerging during treatment of influenza virus infection
002488 (1984) G A Tannock ; J A Paul ; R D BarryRelative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens.
002773 (1980) A. Yamada ; Y. Okuno ; M. Takahashi ; K. NakajimaProduction of an attenuated influenza A (H3N2) strain "KO-1" by recombination with A/Okuda/57 (H2N2) followed by selection of inhibitor-resistant virus.
002859 (1980) J. Drescher [Allemagne] ; U. Desselberger [Allemagne]Antineuraminidase antibody response to vaccination of chickens with intact virus and different subunit preparations of the influenza virus strains A/Sing/1/57 (H2N2), A/Hong Kong/1/68 (H3N2) and A/Port Chalmers/1/73 (H3N2)
002872 (1979) G L Ada ; K L YapThe measurement of haemagglutinin and matrix protein present on the surface of influenza virus infected P815 mastocytoma cells.
002A91 (1977) U. Desselberger [Allemagne]Preparation-conditioned changes of the antigenicity of influenza virus neuraminidases
002A96 (1977) Fujio Suzuki [Japon] ; Noriyuki Saito [Japon] ; Nakao Ishida [Japon]EFFECT OF AN INTERFERON INDUCER, 9‐METHYLSTREPTIMIDONE, ON INFLUENZA VIRUS INFECTION IN MICE
002B89 (1975) Kenkichi Shinkai [Japon]Virucidal Effect of Sodium p‐Chloromercuribenzoate on Influenza Viruses Attributable to Inhibition of Virus Particle‐Associated RNA‐Dependent RNA Polymerase
002D71 (????) G V Kornilaeva ; E V Molibog ; A G Bukrinskaia[pH-dependent hemolytic and neuraminidase activity of remantadine-sensitive and -resistant variants of influenza virus].
002D85 (????) A Iu Egorov ; L M Garmashova ; I V Lukashok ; G N Nevedomskaia ; G I Aleksandrova ; A I Klimov[The NS gene--a possible determinant of apathogenicity of a cold-adapted donor of attenuation A /Leningrad/134/47/57 and its reassortants].
002E21 (????) A R Rekstin ; I V Kiseleva ; Iu A. Desheva ; D. Kats ; G I Aleksandrova ; A I Klimov ; L G Rudenko[Growth characteristics of single gene mutants of A/Leningrad/134/57(H2N2) influenza virus and cold-adapted mutant A/Leningrad/134/17/57(H2N2)].

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021